Achieve Life Sciences Inc (ACHV)
2.35 -0.04 (-1.47%) 09:47 ET [NASDAQ]
2.32 x 100 2.36 x 300
Realtime by (Cboe BZX)
2.32 x 100 2.36 x 300
Realtime 2.50 +0.12 (+5.04%) 09:12 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ACHV | GALT | EPIX | ||
| Company | Achieve Life Sciences Inc | Galectin Therapeutic | Essa Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.36 | 1.3000 | 1.7700 | ||
| High | 2.47 | 1.3000 | 1.7800 | ||
| Low | 2.32 | 1.3000 | 1.7400 | ||
| Last | 2.35 | 1.3000 | 1.7700 | ||
| Change | -0.04 | -0.0200 | -0.0200 | ||
| % Change | -1.47% | -1.52% | -1.12% | ||
| Volume | 7,732 | 615 | 16,073 | ||
| 20-Day Average Volume | 219,119 | 209,140 | 244,334 | ||
| Previous Close | 2.38 | 1.3200 | 1.7900 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.27 | 1.3233 | 1.6495 | ||
| 20-Day Raw Stochastic | 57.14% | 55.56% | 68.04% | ||
| 20-Day Relative Strength | 45.02% | 45.40% | 56.57% | ||
| Weighted Alpha | -55.15 | -22.29 | -22.06 | ||
| Today's Opinion | 88% Sell | 88% Sell | 24% Sell | ||
| Previous Opinion | 88% Sell | 100% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Sell | 40% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.84% since 04/22/25 | +0.76% since 04/21/25 | -1.69% since 04/22/25 | ||
| Low | 2.33 on 04/28/25 | 1.2800 on 04/28/25 | 1.7500 on 04/29/25 | ||
| High | 2.63 on 04/23/25 | 1.4200 on 04/24/25 | 1.9050 on 04/24/25 | ||
| 1-Month | |||||
| %Chg | -15.11% since 03/28/25 | -13.16% since 03/28/25 | +12.18% since 03/28/25 | ||
| Low | 1.84 on 04/09/25 | 1.1200 on 04/04/25 | 1.4200 on 04/09/25 | ||
| High | 2.80 on 03/31/25 | 1.4800 on 04/07/25 | 1.9050 on 04/24/25 | ||
| 3-Month | |||||
| %Chg | -26.71% since 01/29/25 | +7.32% since 01/28/25 | +2.34% since 01/29/25 | ||
| Low | 1.84 on 04/09/25 | 1.1200 on 04/04/25 | 1.4200 on 04/09/25 | ||
| High | 3.79 on 02/11/25 | 1.8207 on 03/26/25 | 1.9050 on 04/24/25 | ||
| 6-Month | |||||
| %Chg | -50.00% since 10/29/24 | -46.99% since 10/28/24 | -67.65% since 10/29/24 | ||
| Low | 1.84 on 04/09/25 | 0.7260 on 12/20/24 | 1.4000 on 11/01/24 | ||
| High | 5.31 on 11/06/24 | 3.1700 on 11/11/24 | 5.5700 on 10/30/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 82,550 | 83,398 | 79,456 | ||
| Shares Outstanding, K | 34,685 | 63,180 | 44,389 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -39,830,000 | -47,050,000 | -28,540,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -12,360,000 | -11,970,000 | -8,530,000 | ||
| 60-Month Beta | 1.59 | 0.79 | 1.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 03/11/25 | -0.19 on 03/31/25 | -0.19 on 02/11/25 | ||
| Latest Earnings Date | 05/08/25 | 05/21/25 | 05/13/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||